To fulfill the extraordinary scientific and medical promise of cancer research and
biomedical science, the AACR respectfully urges Congress to:
• designate the NIH and NCI as national priorities
by providing annual budget increases at least comparable to the biomedical
inflation rate; and
• protect the NIH and NCI from another year of the insidious cuts from
sequestration, and reinstate the $1.6 billion in funding that the NIH lost
in March 2013.
Therefore, the AACR calls on all members of Congress to ensure that funding for cancer
research and biomedical science is strongly supported. The AACR also urges
all Americans — the beneficiaries of this lifesaving research —
to make their voices heard by encouraging their policymakers to provide
sustainable funding increases for the NIH.
If we are to ultimately transform scientific discoveries into
therapies that improve and save the lives of cancer patients, it is going to require
an unwavering commitment of Congress and the administration to invest
in our country’s remarkably productive cancer research and biomedical
research enterprise led by the NIH and NCI.
The AACR Call to Action
